Compare Diastika Biotekindo Tbk. (CHEK) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diastika Biotekindo Tbk. vs Merck Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp126 (market cap 518.28B), while Merck Tbk. trades at Rp3,800 (market cap 1.7T). The key difference: Merck Tbk. is far larger — about 3.3× Diastika Biotekindo Tbk.'s market cap. Which is the better fit depends on your goals.
| CHEK | MERK | |
|---|---|---|
Market Cap | 518.28B | 1.7T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diastika Biotekindo Tbk.
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
